- Report
- August 2023
- 51 Pages
Turkey
From €567EUR$600USD£473GBP
- Report
- August 2023
- 51 Pages
Israel
From €567EUR$600USD£473GBP
- Report
- August 2023
- 51 Pages
Colombia
From €567EUR$600USD£473GBP
- Report
- August 2023
- 51 Pages
India
From €567EUR$600USD£473GBP
- Report
- August 2023
- 202 Pages
South Africa
From €3305EUR$3,500USD£2,759GBP
- Report
- August 2023
- 63 Pages
Vietnam
From €1884EUR$1,995USD£1,573GBP
- Report
- June 2023
- 65 Pages
Global
From €4674EUR$4,950USD£3,902GBP
- Training
- May 2023
- 2 Days
Global
From €1740EUR$1,843USD£1,452GBP
- Report
- March 2023
- 185 Pages
Global
From €2361EUR$2,500USD£1,971GBP
- Report
- February 2023
- 123 Pages
Global
From €2361EUR$2,500USD£1,971GBP
- Report
- January 2023
- 306 Pages
Global
From €3966EUR$4,200USD£3,311GBP
- Report
- November 2022
- 220 Pages
Global
From €3258EUR$3,450USD£2,719GBP
- Report
- November 2022
- 220 Pages
Global
From €3258EUR$3,450USD£2,719GBP
- Report
- August 2022
- 180 Pages
Global
From €5665EUR$6,000USD£4,729GBP
- Report
- August 2022
- 382 Pages
Global
From €3305EUR$3,500USD£2,759GBP
- Report
- July 2022
- 317 Pages
Global
From €3305EUR$3,500USD£2,759GBP
- Report
- January 2022
- 194 Pages
Global
From €2077EUR$2,200USD£1,734GBP
- Report
- August 2021
- 159 Pages
Global
From €5193EUR$5,500USD£4,335GBP
- Report
- May 2021
- 358 Pages
Global
From €2597EUR$2,750USD£2,168GBP
- Report
- January 2020
- 156 Pages
Japan
From €4249EUR$4,500USD£3,547GBP

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers.
Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more